Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318705 · ClinicalTrials.gov registry record
Testing Latest Version of NidekRS3000Adv
A clinical trial of Glaucoma, sponsored by Doheny Image Reading Center.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03318705: Completed study of Glaucoma, sponsored by Doheny Image Reading Center.
NCT03318705 is a study of Glaucoma that has completed, run by Doheny Image Reading Center. The registered enrollment target is 100 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03318705, a study of Glaucoma, has completed, sponsored by Doheny Image Reading Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.
Primary Outcome
Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants
Conditions Studied
Interventions
- DEVICE RS3000Adv
Study Locations (1)
California
- Doheny Eye Centers UCLA - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2018-03-28 |
What the finished NCT03318705 record still lists
NCT03318705 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which RS3000Adv is the first listed.
NCT03318705 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03318705 about?
NCT03318705 is a clinical study titled "Testing Latest Version of NidekRS3000Adv". The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participan...
What is the current status of trial NCT03318705?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-02-01. Estimated completion is 2018-03-28.
What conditions does trial NCT03318705 study?
This clinical trial studies the following conditions: Glaucoma.
What interventions are being tested in trial NCT03318705?
The interventions under investigation include: RS3000Adv (DEVICE).
Who is sponsoring clinical trial NCT03318705?
This trial is sponsored by Doheny Image Reading Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03318705 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03318705's enrollment target sits among peer trials
100 44th of 92 higher than 48 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI